New Pharma Regs Have Created a Perfect Storm for the Industry – AI Is the Fix

Following a recent slew of regulations, pharma companies are increasingly struggling to roll out their products, falling at the commercialisation hurdle. US and EU policies have created a perfect storm for the industry, raising costs and reducing successful launches of new drugs. While many firms are turning to AI for research support, I predict that the technology's greatest value will lie in this area, and in fixing this challenge. By identifying the patient subgroups who would benefit the…

This article has been indexed from Unite.AI

Read the original article: